The current valuation score of Merck & Co Inc is 9.09, ranking 46 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 43.85, which is 1991.34% below the recent high of 917.15 and 75.70% above the recent low of 10.66.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.